The Company

We are Biosidus, an Argentina-based company with an impressive track-record in the development, manufacture and supply of top quality biosimilars commercially available across four continents through a vast network of licensees.

We focus our current R&D activities on accelerating market entry of our robust pipeline of biosimilars and on other innovative technologies such as Gene Therapy applied to the management of central and peripheral vascular disease and Transgenic Animals, productive technological platform to obtain human proteins and functional food.

More

News/ view all

JUNE 2018

Biosidus at Bio International Convention

More

OCTOBER 2016

Biosidus at CPhI

More

SEPTEMBER 2016

Biosidus at ECTRIMS 2016

More

International Presence

  • With more than two decades of expertise in the manufacture and distribution of high quality biosimilar products in emerging market countries, a strong portfolio and pipeline of products, significant development and manufacturing capabilities and an established network of distribution partners, we believe we are well positioned to take advantage of opportunities for growth in the global biosimilar therapeutics market

    / More